These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1657076)

  • 1. Dose-response relationships in testicular cancer.
    Cullen MH
    Eur J Cancer; 1991; 27(7):817-8. PubMed ID: 1657076
    [No Abstract]   [Full Text] [Related]  

  • 2. Testicular germ cell tumours - still many challenges.
    Dahl O; Brydøy M
    Acta Oncol; 2012 Feb; 51(2):147-50. PubMed ID: 22263970
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory testis cancer: salvage or savage chemotherapy?
    Levine EG; Raghavan D
    Eur J Cancer; 1991; 27(7):932-6. PubMed ID: 1657079
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for germ-cell tumours.
    Newlands ES; Begent RH; Rustin GJ; Bagshawe KD
    Lancet; 1983 Jul; 2(8342):163. PubMed ID: 6135007
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
    Kenis Y; Piccart M; Beer M
    Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumors of ovary and testis (author's transl)].
    De Jager R
    Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206
    [No Abstract]   [Full Text] [Related]  

  • 8. Etoposide salvage therapy for refractory germ cell tumors: an update.
    Williams SD; Einhorn LH
    Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance.
    Al-Obaidy KI; Chovanec M; Cheng L
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):75-79. PubMed ID: 31951790
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisplatin-related Cerebral Infarction in Testicular Germ Cell Cancer: Short Report of Three Cases and P in testicular germ cell cancer: Short report of three cases and pathomechanism.
    Lange J; Audebert HJ; Endres M; Rocco A
    Clin Neurol Neurosurg; 2017 Jan; 152():76-77. PubMed ID: 27923208
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.
    Nichols C; Kollmannsberger C
    J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Richie JP
    J Urol; 2013 Nov; 190(5):1767-8. PubMed ID: 24120784
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
    Pizzocaro G; Guarneri A
    Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
    [No Abstract]   [Full Text] [Related]  

  • 16. In germ cell cancer, are we at the end of the chemotherapy era? Maybe--and we are certainly at the end of the RCT era.
    Maroni P
    Oncology (Williston Park); 2013 Nov; 27(11):1136, 1143. PubMed ID: 24575541
    [No Abstract]   [Full Text] [Related]  

  • 17. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 19. High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor.
    Connell BJ; Patel MJ; Tretter CG
    Clin Genitourin Cancer; 2016 Aug; 14(4):e441-3. PubMed ID: 27055370
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.